We prospectively studied the effect of human immunodeficiency virus (HIV) infection on the presentation and outcome of tuberculosis. A total of 216 patients with tuberculosis were identified; 162 (75%) of these patients were tested for antibodies to HIV; 92 (57%) were seropositive. The patients who were seropositive for HIV were more likely to be male and Hispanic and to have been homeless or incarcerated. Eighty-one percent of these patients had CD4 lymphocyte counts of 200/mm3. The seropositive patients had extrapulmonary tuberculosis more often than did the seronegative patients (odds ratio [OR], 2.3; 95% confidence interval [CI], 1.2-4.8). Smears for acidfast bacilli were positive more often for non-HIV-infected patients with pulmonary tuberculosis (74.5%) than for HIV-infected patients (54.3%) [OR, 2.46; 95% CI, 1.01-6.02]-even those with focal or cavitary disease. A delay in initiating therapy was associated with in-hospital mortality: the median time from admission to the start of treatment was 4 days for patients who survived and 15 days for those who died (P = .02). The median survival was 22.7 months for HIV-infected patients who did not die during the initial hospitalization. Factors independently associated with reduced rates of survival included the severity of immunodeficiency, nonuse of directly observed therapy, infection due to drug-resistant Mycobacterium tuberculosis, and a history of injection drug use.
After decades of decline, the annual incidence of tuberculosis (TB) in the United States rose each year from 1985 to 1992 [1] . Factors contributing to this increased incidence included the epidemic of HIV infection, an increase in the frequency of antibiotic-resistant Mycobacterium tuberculosis isolates, a decline in the public health infrastructure, the spread of TB in congregate settings such as homeless shelters and jails, and immigration from countries with high rates of TB [2, 3] . The presence of HIV infection greatly increases the risk that individuals with longstanding or recently acquired M. tuberculosis infection will develop active disease [4, 5] .
Numerous clinical studies of TB in HIV-infected patients in the United States have been reported previously. However, many of these studies had substantial limitations: only subsets of patients with TB were included; these studies were restricted according to gender, risk behaviors, anatomic site of tuberculosis, drug susceptibility, or stage of HIV disease; data collection was retrospective or not stated as being prospective; there was either no information or limited information about risk factors for TB; no seronegative comparison group was included; there was little or no information about drug susceptibility; or the sample size was limited (50 subjects) [2, 4, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Although there are substantial data showing that rates of mortality and morbidity are higher among patients with active TB and concomitant HIV infection than among non-HIV-infected patients with tuberculosis [21] [22] [23] , information about the factors that influence survival among HIV-infected patients is limited [24, 25] . Knowledge of such factors offers the potential for optimizing interventions to improve survival.
To study the impact of HIV infection on the presentation of TB and to identify factors affecting survival of coinfected patients at our institutions in the Bronx, New York City (a community beset by the converging epidemics of these two diseases), we prospectively studied all patients who presented with tuberculosis at our medical centers, and we followed up the HIV-infected patients after hospital discharge.
Methods
From July 1992 through June 1995, we prospectively studied all patients at two hospitals in the Bronx, New York City, for whom cultures of any anatomic site yielded M tuberculosis. The hospitals were the Moses Division of Montefiore Medical Center, a voluntary medical center that is the largest provider of care to residents of the Bronx, and its physically adjacent municipal affiliate, North Central Bronx Hospital. After identification, hospitalized patients were interviewed by two (P.L.A. and S.S.M.) of the authors and followed up prospectively until death or hospital discharge. HIV-infected patients were followed up prospectively, as detailed below.
A standardized interview was conducted to ascertain demographic factors, past behavioral risk factors, and medical histories. For Spanish-speaking patients, interviews were conducted in Spanish, and for children, interviews were conducted with parents. We reviewed the medical records of patients previously seen at our institutions for documentation of prior AIDS-defining clinical conditions and TB.
Alcoholism was defined as the consumption of > 12 drinks per week, and homelessness was defined as the lack of a home for _-2 weeks within the preceding 6 months. For patients who refused to be interviewed or who died before the diagnosis of TB was made, alcoholism and homelessness were ascertained by reviewing the medical charts. We reviewed the medical records and recorded the results of tests including smears, histology, cultures, antimicrobial susceptibility testing, and chest radiographs.
Specimens were processed for isolation of mycobacteria by means of standard methods [26] . Concentrated sputum smears were stained with auramine-rhodamine, and those found to be positive for acid-fast bacilli were examined with a Kinyoun carbolfuchsin stain for confirmation. All cultures were inoculated into Bactec 12B bottles (Becton-Dickinson, Sparks, MD), incubated for 6 weeks at 37°C, and read on the basis of a 7-day protocol, according to the recommendations of the manufacturer [27] . Specimens were also inoculated onto slant cultures containing LOwenstein-Jensen culture medium, incubated for 6-8 weeks, and examined weekly. All mycobacterial isolates were identified by using criteria described by the Centers for Disease Control and Prevention (CDC) [26] , by using genetic probes, or by using both methods.
Isolates of M. tuberculosis complex were tested for susceptibility to first-line antituberculous drugs (i.e., isoniazid, streptomycin, rifampin, ethambutol, and pyrazinamide [provided by Becton-Dickinson]) with the Bactec 460 system, according to the recommendations of the manufacturer [27] . The susceptibility patterns of isolates that were resistant to either isoniazid or rifampin and of those that were resistant to two or more of any first-line antituberculous drugs were confirmed by using the agar proportion technique [26] .
For isolates recovered at Montefiore Medical Center that were resistant to one or more first-line agents, susceptibility to second-line drugs was tested on Middlebrook 7H10 medium at the following concentrations: p-aminosalicylic acid, 2 p,g/mL (Becton-Dickinson); ethionamide, 5 pg/mL, and kanamycin, 6 ktg/mL (BBL Microbiology Systems, Cockeysville, MD); cycloserine, 10 p,g/mL before 1994 and 30 ug/mL since 1994; and capreomycin, 10 Patients not known to have HIV infection were offered HIV counseling and testing (EIA with western blot confirmation), as recommended for all patients with TB [28] . T cell subset determinations were recommended for all HIVinfected patients. When patients had not had T cell subset determinations made at the time that TB was diagnosed, we ascertained the last recorded CD4 cell count before the diagnosis of TB was made.
The dates of hospital admission and initiation of antituberculous therapy were recorded. Patients were treated for TB as directed by their primary care physicians. For analysis of the interval between hospital admission and initiation of therapy, we used the interval between admission and the thy after death for individuals who died without receiving any antituberculous therapy. All ambulatory patients with TB were offered directly observed therapy (DOT). DOT was defined as the administration of antituberculous medication by a trained health care worker.
Follow-up was arranged whenever possible in the clinics of the medical center. If HIV-infected patients were being followed up by private physicians, these clinicians were contacted periodically for information about their patients' conditions. If patients were rehospitalized, we reviewed their medical records to obtain information on possible relapses of TB and the development of other opportunistic infections.
At the end of the study period, we again reviewed all records at the two hospitals to ensure that no hospitalizations had been overlooked and to verify the T cell subset data. We searched the Death Registry and the Tuberculosis Registry of New York City to obtain additional information on patients lost to followup and to determine whether any of the patients had previously been reported as having tuberculosis. All patients who survived were censored from the study on 23 May 1995. Death was attributed to TB if a culture for M tuberculosis had been positive in the month before death and there was no other identified cause of death. Autopsies were not routinely performed.
Data management and analysis were performed with dBASE (Borland International, Scotts Valley, CA) software and EpiInfo Version 6 software (CDC). Categorical variables were analyzed with use of the x2 test or Fisher's exact test where appropriate; continuous variables were analyzed with use of the Kruskall-Wallis test. Findings were considered statistically significant when the P value was .05. All tests were twotailed. For selected analyses, we calculated odds ratios and 95% confidence intervals. We analyzed survival by the method of Kaplan-Meier; we performed multivariate analyses, which were based on the Cox regression model, with use of the SPSS 6.1 for Windows statistics program (SPSS Inc., Chicago). Interaction effects were evaluated, and the resulting hazard ratios and 95% confidence intervals were obtained.
Results
From July 1992 through June 1995, 221 patients had M tuberculosis isolated from one or more specimens at our two institutions. Five patients were excluded from the analysis for the following reasons: only one culture was positive for M tuberculosis; there was a strong suspicion that the results were erroneous (in two cases there was evidence of mislabeling of a sample from a roommate); the primary care physicians concluded that the isolate did not represent a true infection; and although no treatment for TB was given, there was no further suggestion that the patients were infected.
Of the 216 patients included in this report, most were either Hispanic (44%) or African-American (37%). One hundred ninety-seven patients (91.2%) were interviewed; 11 died in the hospital before they were interviewed, three could not be interviewed because of altered mental status, and five were discharged from the hospital and lost to follow-up before they could be interviewed. For these 19 patients, historical information was abstracted from the medical records.
The median age of the patients was 38 years (range, <1-95 years). Two hundred eleven patients (97.7%) were at least 15 years of age (median age, 39 years). Seventeen percent of these patients had been homeless, 21% had a history of alcoholism, and 19% had been incarcerated. A history of psychiatric illness was reported by 5% of those interviewed.
Sixty-seven (31%) of the 216 patients had previously been found to be infected with HIV. Of the remaining 149 patients, 95 (63.8%) underwent testing for antibodies to HIV, 25 (26.3%) of whom were found to be seropositive. Therefore, of the entire sample, 92 patients (42.6%) were seropositive for HIV, 70 (32.4%) were seronegative, and 54 (25%) did not undergo testing. There were no significant differences with respect to age, history of homelessness, or history of prior episodes of TB when patients of known HIV status were compared with those of unknown status. However, the former patients were significantly more likely to be male, to have a history of alcoholism, and to be Hispanic than were the latter patients.
Demographic characteristics and possible risk factors for tuberculosis, according to HIV status, are shown in table 1. HIV-infected patients were more likely to be Hispanic, to have been homeless or incarcerated, and to be male. They were not more likely to have a history of tuberculosis or alcoholism. The HIV-infected patients were also more likely to have been injection-drug users or to have had same-sex partners (data not shown).
Fifty HIV-infected patients (54.3%) had had their T cell subsets measured at the time that TB was diagnosed. The median CD4 cell count was 71/mm3 (range, 5-1,362/mm3), and CD4 cell counts were .--_.200/mm3 for 81% of these patients. Among an additional 35 HIV-infected patients whose T cell subset levels were not determined when TB was diagnosed, the median CD4 cell count before the diagnosis of TB was 49.5/mm3 (range, 0-534/mm3). HIV-infected patients with extrapulmonary infection were more likely to have concomitant pulmonary disease than were non-HIV-infected patients with extrapulmonary infection (OR, 4.2; 95% CI, 1.3-14.3). CD4 cell counts did not differ between HIV-infected patients with extrapulmonary tuberculosis-with or without concomitant pulmonary involvement (median CD4 cell count, 75.5/mm3 ; range, 1 -424/mm3)-and those with pulmonary disease alone (median CD4 cell count, 71/mm3 ; range, 0-1,362/mm3 ; P = .6).
Of the 124 patients with pulmonary tuberculosis, 117 (94.4%) had positive sputum cultures; bronchoscopic specimens, gastric aspirates, or lung biopsy specimens were positive for the seven remaining patients. Since none of these patients had pharyngeal or laryngeal tuberculosis alone, all were assumed to have pulmonary involvement regardless of the findings on chest radiographs. Focal infiltrates, upper-lobe infiltrates, and cavitary disease were each significantly less likely to be present in HIV-infected patients (table 2) . Intrathoracic lymphadenopathy was seen on the chest radiographs of HIVinfected patients significantly more frequently than on the radiographs of non-HIV-infected patients. The findings on chest radiographs were normal for a small proportion of patients with pulmonary tuberculosis, with or without HIV infection.
Acid-fast smears of sputum were performed for 64 (88.9%) of 72 HIV-infected patients and 43 (82.7%) of 52 non-HIVinfected patients with pulmonary tuberculosis. Acid-fast stains were positive significantly more often for HIV-seronegative patients with positive sputum cultures (74.5% of patients) than for HIV-infected patients (54.3%) (OR, 2.46; 95% CI, 1.01-6.02).
Among patients with pulmonary tuberculosis and positive sputum cultures who had either focal infiltrates or cavities apparent on chest radiographs, non-HIV-infected patients were significantly more likely to have positive sputum acid-fast smears than were HIV-infected patients (34 of 41 patients [82.9%] vs. 20 of 39 [51.3%], respectively; OR, 4.6; 95% CI, 1.5 -14.9). Additional smears were performed for 34 (87.2%) of 39 HIV-infected patients with pulmonary TB vs. 20 (87.0%) of 23 non-HIV-infected patients with pulmonary TB; therefore, differences in the rates of positive smears according to HIV status cannot be explained by the fact that more smears were done for non-HIV-infected patients.
The antimicrobial susceptibilities of the M tuberculosis isolates are shown in table 3. HIV-infected patients tended to be infected somewhat more often with drug-resistant isolates, but this difference approached statistical significance only for rifampin (P = .09). Of the isolates that were resistant to both isoniazid and rifampin (i.e., multidrug-resistant isolates), 15 (93.8%) of 16 were susceptible to three or more alternative antimicrobials, and the remaining isolate was susceptible to two alternative drugs. The small number of multidrug resistant isolates tested in this study were uniformly susceptible to ci- profloxacin and capreomycin; in contrast, the proportion of these isolates that were resistant to the first-line antimicrobial agents (streptomycin, ethambutol, and pyrazinamide) equaled or exceeded 50 percent. Multidrug-resistant isolates were recovered from five (20.0%) of 20 patients with a history of TB vs. 11 (8.1%) of 136 without a history of TB (P = .08).
Factors associated with in-hospital mortality are shown in table 4 for patients hospitalized at the time that TB was diagnosed. A trend towards increased mortality was observed for both HIV-infected patients and those with multidrug-resistant TB. A longer delay between admission and institution of antimicrobial therapy was also associated with increased mortality.
We included three outpatients and 74 HIV-infected patients who had enrolled in the study by 1 March 1995 and who survived initial hospitalization in the analyses of survival of patients who did not die during the initial hospitalization. There were no significant demographic differences between these patients and the HIV-infected patients who died during hospitalization. The estimated median survival was 22.7 months for these 77 patients (figure 1). Thirty-two patients (41.6%) died during follow-up; at least 11 (34.4%) of these deaths were attributable to TB. Univari- .02
* M tuberculosis isolate susceptible to isoniazid, rifampin, or both. I The number of days between admission and institution of therapy for tuberculosis for hospitalized patients, excluding those with multidrug-resistant infections. included a substantial sample as well as women, patients with varying risk factors, HIV-seronegative patients for comparison, and prospective evaluation and follow-up of patients, renders its conclusions more rigorously scientific. We were able to document HIV status for three-quarters of our sample. Forty-three percent of all patients (57% of those whose HIV status was known) were infected with HIV. HIVinfected patients were more likely to be male and Hispanic; both of these characteristics are associated with HIV infection in the Bronx [29] . Seronegative patients were more than three times as likely to identify themselves as a nationality other than American or Puerto Rican than were HIV-seropositive patients; this finding suggests that the association between TB and foreign birth is less important for HIV-infected persons, as has been noted previously [12] . A history of prior incarceration, known to be associated with both the risk for TB [3] and illicit drug use, was also significantly more common among HIVinfected patients.
TB commonly occurs earlier in the course of HIV infection than do many other opportunistic infections, and this finding has been ascribed to the greater virulence of TB [6, 7, 9, 30] . Median CD4 cell counts in previous reports of tuberculosis in HIV-infected patients have ranged from < 150/mm3 to >300/mm3 [9, 13, 17, 19, 31] . Lower median CD4 cell counts have been described for HIV-infected persons with disseminated or multidrug-resistant TB [10, 15, 20] . In the present series, we did not observe differences in CD4 cell counts among HIV-infected patients with extrapulmonary TB and those without extrapulmonary TB. Our patients generally had advanced HIV disease; > 80% of those with documented HIV infection met the 1993 revised case definition of AIDS that was published by the CDC [32] , even when we did not take the presence of TB into account.
There are several potential explanations for the finding of advanced disease in such a large proportion of the patients in our study. One explanation may be recent acquisition of M tuberculosis infection, with rapid progression to disease among patients with advanced HIV infection; such progression was described previously for more than one-third of patients with TB at our institutions [33] . Other explanations for this finding may be the relatively long duration of the HIV epidemic among our patient population and the fact that many of our HIV-infected patients received routine TB prophylaxis and thus did not develop TB until the onset of severe immunodeficiency [34] . Finally, we designed our study to include only patients with TB that was confirmed by culture at our medical centers, which likely resulted in the exclusion of some patients with TB and less advanced HIV disease.
The prompt diagnosis of TB is important for optimal treatment as well as for institution of necessary infection control procedures, to protect both health care workers and other patients [35] . We found that TB involving the lungs was equally frequent among patients with HIV infection and those who were seronegative for the virus. However, acid-fast smears of sputum were less likely to be positive for HIV-infected patients-even those with focal or cavitary disease potentially contributing to a delay in diagnosis and treatment.
Patients with HIV infection were more likely to have extrapulmonary disease, alone or in combination with pulmonary tuberculosis. Regardless of HIV status, >20% of our patients had extrapulmonary infection without accompanying lung involvement. Such patients often present with nonspecific signs and symptoms, and the diagnosis of TB may be difficult. Clinicians should suspect TB in all patients with compatible clinical syndromes; this is especially true for those with HIV infection because they are more likely to have atypical presentations.
A recent report from the health department in Miami suggests that patients with TB and HIV infection are less infectious to contacts than are patients without HIV infection [36] . Although the results of several studies have suggested that the rates of positive acid-fast smears of sputum are lower among HIV-infected patients with pulmonary TB [8, 37] , the results of other studies have not demonstrated this finding [7, 9, 38] .
In the present study we found a significantly higher rate of positive sputum smears for HIV-seronegative patients whose sputum cultures were positive for M. tuberculosis than for HIVinfected patients with positive sputum cultures. This finding could not be explained by different frequencies of sputum smear examinations between the two groups. A possible explanation is that HIV-related immunosuppression impairs the normal cellular response to TB, making pulmonary consolidation, necrosis, and cavitation (with its associated high mycobacterial load) less likely to occur. The lower rates of focal and cavitary disease observed among HIV-infected patients are consistent with this hypothesis.
However, even among patients with focal or cavitary disease, those infected with HIV were significantly less likely to have positive sputum smears than were the non-HIV-infected patients. This finding suggests that there is an additional explanation for the observed differences that is not readily apparent. Even if HIV-seropositive patients with pulmonary TB are less infectious than are seronegative patients, a high index of suspicion must be maintained for HIV-infected patients who develop signs or symptoms suggestive of TB.
The incidence of multidrug-resistant TB in New York City has risen dramatically in recent years [39, 40] , in large part because of suboptimal compliance with therapy among patients with TB [2, 39] . In the present study, a history of TB was more common among patients who had multidrug-resistant TB. This difference approached statistical significance and is consistent with the finding that prior suboptimal therapy is a major contributor to the development of multidrug-resistant TB. Alternatively, this difference could have been due to a higher relapse rate (and subsequent eligibility for this study) among previously treated patients with multidrug-resistant disease than among patients with susceptible infections.
Although the rates of drug resistance were slightly higher for HIV-seropositive patients than for HIV-seronegative patients, the differences did not reach statistical significance with our sample size. In the treatment of multidrug-resistant tuberculosis, the best response is obtained with the administration of multiple agents to which the isolate is susceptible [16] .
Fortunately, all multidrug-resistant isolates in this series were susceptible to two or more alternative antimicrobial agents. Although the in-hospital mortality was somewhat higher for patients with multidrug-resistant infections, a delay in instituting therapy was the factor that was significantly associated with death. Therefore, a reduction in in-hospital mortality should be possible if a high index of suspicion leads to early diagnosis and initiation of appropriate chemotherapy.
We found that several factors affected long-term survival. Decreased survival was associated with severity of immunodeficiency, as would be expected for HIV-infected patients, even those without TB. In contrast to a recent somewhat smaller retrospective study in which the investigators demonstrated that severity of immunodeficiency was the only factor independently associated with decreased survival of HIV-infected patients with TB [25] , our study showed that there were other independent predictors of decreased survival, even when we controlled for level of immunodeficiency. The association between DOT and improved survival confirms that compliance with treatment is important [23] [24] [25] 41] .
Although the injection drug users were similar to other patients in terms of demographics and in location and duration of follow-up, survival was decreased among injection drug users independent of antimicrobial susceptibility and the use of DOT. Previous studies have shown that the survival rates are lower among injection drug users with HIV infection than among patients who are not injection drug users [42, 43] , while other studies have shown that with similar medical care, survival does not differ [44] . The reason for decreased survival among injection drug users with TB in the present study is not clear but might be the fact that the incidence of bacterial infections was higher among these patients [45] . Unfortunately, we did not prospectively assess for incident bacterial infections.
We recognize several limitations to the present study. While the population of the Bronx is similar to that of other inner cities, our exclusion of patients whose cultures were negative for M tuberculosis or whose cultures were not performed in our medical center laboratories may limit the extent to which our findings can be generalized. Patients with TB that was diagnosed clinically or whose positive cultures were performed elsewhere were not included. Furthermore, the HIV epidemic has existed longer in New York City than in many other areas of the country.
Therefore, the findings of this study should be applied cautiously to patients in other locations. In addition, although the patients with TB and unknown HIV statuses were similar in terms of age, history of homelessness, and history of tuberculosis to those with known HIV statuses, the former patients were more likely to have been male, have a history of alcoholism, and be Hispanic. Although this raises the possibility of some bias in our observations, the data are consistent with those from prior reports.
The results of the present study suggest that several interventions have the potential for improving survival among HIVinfected patients with TB. Prompt diagnosis and aggressive treatment of TB are important for improving survival. DOT should be implemented whenever possible, particularly for patients with drug-resistant TB. As improved antiretroviral therapies become available, maintaining or improving the immune status of patients is likely to have an important effect. Finally, the treatment of substance abuse could mitigate the adverse impact of the resultant complications on survival.
